Table IStakeholder identification and prioritization of clinical outcomes of greatest importance for future research of insulin delivery and glucose monitoring methods among patients with type 2 diabetes by population

Phase 1: IdentificationPhase 2: Number of Stakeholders Rating Research Gap as Highest Priority (n=5)Phase 3: Number of Stakeholders Re-rating Gap as Highest Priority (n=5)Phase 4: High Priority Gap(s) Included as Part of the Final Research Question in Final Research Questions
Adolescents
HbA1c2*
Adherence1*
Non-severe hypoglycemia0*
Severe hypoglycemia1*
Hyperglycemia0*
Weight1*
Adults
HbA1c3*‡
Adherence1*
Non-severe hypoglycemia0*
Severe hypoglycemia0*
Hyperglycemia1*
Weight0*
Elderly
HbA1c3*
Adherence0*
Non-severe hypoglycemia0*
Severe hypoglycemia1*
Hyperglycemia1*
Weight0*

Abbreviation: HbA1c = hemoglobin A1c

*

Indicates consensus achieved in the previous round; reprioritization not required.

‡

Indicates an identified research need.

From: Executive Summary

Cover of Insulin Delivery and Glucose Monitoring Methods: Future Research Needs
Insulin Delivery and Glucose Monitoring Methods: Future Research Needs: Identification of Future Research Needs From Comparative Effectiveness Review No. 57 [Internet].
Future Research Needs Papers, No. 32.
Yeh HC, Lau BD, Golden SH, et al.
Copyright Notice

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.